Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway

Citations Over TimeTop 12% of 2013 papers

Abstract

Together, our findings indicate that Lcn2 can negatively modulate the EMT in HCC cells through an EGF (or TGF-β1)/Lcn2/Twist1 pathway. Thus, Lcn2 may be a candidate metastasis suppressor and a potential therapeutic target in HCC.

Related Papers

• → miR‐96 regulates migration and invasion of bladder cancer through epithelial‐mesenchymal transition in response to transforming growth factor‐β1(2018)31 cited
• → Betulinic acid suppresses NGAL-induced epithelial-to-mesenchymal transition in melanoma(2013)34 cited
• 발생중 마우스 배자에서 Transforming Growth Factor-α와 Epidermal Growth Factor의 발현차이(1995)
• TGF-β induced epithelial-mesenchymal transition and the related therapeutic strategy(2009)
• → Study and prospects of transforming growth factor-β induced epithelial-mesenchymal transition on pulmonary fibrosis(2012)